Heat Biologics announced collaboration with Waisman Biomanufacturing to manufacture COVID-19 vaccine
On May 27, 2020, Heat Biologics announced a collaboration with Waisman Biomanufacturing to establish a partnership for the…
-
-
Quest Diagnostics launched COVID-19 workforce testing services to help organizations in fostering safer workplaces
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
-
IAVI and Merck announced collaboration to develop vaccine against SARS-CoV-2
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
-
Philips launched next generation wearable biosensor for early patient deterioration detection for COVID-19
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
-
Dementia gene raises risk of severe COVID-19
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
-
Merck and Ridgeback Bio announced collaboration to advance development of novel antiviral candidate, EIDD-2801
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
-
Innovation Pharma receives data from public health research institute showing brilacidin inhibits SARS-CoV-2 (COVID-19) in human cell line
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
-
Cerecor and Myriad Genetics announced levels of novel cytokine, LIGHT highly correlated with disease severity and mortality in COVID-19 ARDS biomarker study
Cerecor and Myriad Genetics announced that levels of novel cytokine, LIGHT, were highly correlated with disease severity and…
-
Montefiore and Einstein tested new drug combination to conquer COVID-19
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine announced they have begun the…
-
Todos Medical announced cross-distribution agreement with L1 Systems for ventilators and COVID testing
On May 26, 2020, Todos Medical announced that it had entered into a cross-distribution agreement with L1 Systems, Ltd., a…
-
Meridian Bioscience supply reagents for manufacturing of tens of millions of COVID-19 antibody tests per month
On May 26, 2020, Meridian Bioscience announced that its SARS-CoV-2 antigens and related reagents are part of assays…
-
Rice University COVID-19 research fund awarded final grants
On May 26, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had awarded…
-
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
-
OraSures OMNIgene-ORAL kit included in EUA granted to P23 labs for at-home collection of saliva samples for SARS-CoV-2 test
On May 22, 2020, OraSure Technologies announced that its OMNIgene-ORAL saliva collection device (OM-505) was included in the…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
-
Sinovac secured $15 million in funding to accelerate COVID-19 vaccine development
On May 22, 2020, Sinovac Biotech announced a transaction in which Advantech Capital and Vivo Capital have invested…
-
Analysis of COVID-19 genomes revealed large numbers of introductions to the UK in March, 2020
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
-
The FDA posted list of antibody tests removed from the ‘notification list’ of tests being offered during the public health emergency
On May 21, 2020, the U.S. Food and Drug Administration (FDA) posted list of antibody tests removed from…
-
Abbott announced contract to supply millions of IgG lab-based antibody tests to UK government
On May 21, 2020, Abbott announced a government contract to supply millions of its laboratory-based IgG antibody tests…
-
Abbott released interim clinical study data on ID NOW COVID-19 rapid test showing strong agreement to lab-based molecular PCR tests
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
-
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
-
bioMerieux serology tests for SARS-CoV-2 on VIDAS received CE marking
On May 21, 2020, bioMerieux announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people…
-
University of British Columbia researchers developed biodegradable medical mask for COVID-19
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
-
ADMA Biologics commenced collection of COVID-19 plasma from recovered patients
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…
-
Amarin supported trial to investigate effects of VASCEPA (icosapent ethyl) in treatment of COVID-19
On May 21 2020, Amarin announced support for a clinical trial to investigate the effects of icosapent ethyl…
-
Biotechnology | COVID-19 | NIH | Therapeutics
Study of BioAegis’ lead product, Gelsolin, key component of NIAID strategic plan for COVID-19 research
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
-
Montefiore-Einstein Scientists lead two trials of leronlimab for treatment of severe lung inflammation in COVID-19 patients
On May 21, 2020, Montefiore Health System and Albert Einstein College of Medicine were the first sites in…
-
Bharat Biotech and Thomas Jefferson University announced a promising vaccine candidate against COVID-19
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
-
ARENSIA Begins Clinical Trial Program to Test Diffusion’s Lead Drug for the Treatment of Hospitalized COVID-19 Patients
On May 20, 2020, ARENSIA announced an agreement with Diffusion Pharmaceuticals to begin a clinical trial program to test…
-
Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossa’s proprietary COVID-19 drug…
